MECHANISM AND BEHAVIOR OF SYMPTOMATIC TACHYCARDIA
MECHANISM AND BEHAVIOR OF SYMPTOMATIC TACHYCARDIA
批准号:
6415285
负责人:
EDWARD L PRITCHETT
金额:
$29.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-12-01 至 2001-11-30
中文摘要
杜克大学医学中心临床药理学和心脏病学部门的研究人员利用兰金综合临床研究中心研究心房颤动和其他常见心律紊乱患者。房颤是最常见的心律紊乱,需要抗心律失常药物治疗,在美国因心律失常住院的患者中,房颤占三分之一以上。心房颤动患者通常正常的心律被快速、不规则的心脏跳动所取代,这可能导致胸部搏击感、呼吸短促、胸痛、头晕或意识丧失。这些症状可能持续几分钟或几小时,也可能无限期持续,除非医生给予紧急治疗。Rankin综合临床研究中心开展的研究主要集中在阐明房颤及心律相关疾病的机制、临床病程和最佳治疗。这些研究的重点是测量自发性心房颤动和阵发性室上性心动过速的频率。在研究的150名停止抗心律失常药物治疗的患者中,一半的患者在大约3周内出现了自发的症状性复发;事实上,大约五分之一的患者在不到一天的时间内出现心律失常症状性复发。房颤患者复发时的平均心率为132次/分,阵发性室上性心动过速患者的平均心率为198次/分。在房颤患者中,约有1 / 9的患者伴有第二次心律失常,即心房扑动。无症状心律失常发生率约为有症状心律失常发生率的12倍。奇怪的是,生活质量并没有受到心律失常发生频率的影响。类似的方法也被用于研究植入心律转复除颤器(ICD)的室性心动过速患者。在这个人群中,ICD电击的频率提供了室性心动过速发生的估计。约1/3的患者在1个月内发生室性心动过速。这些研究结果对设计慢性抗心律失常药物治疗的临床试验具有重要意义。
英文摘要
Investigators in the Divisions of Clinical Pharmacology and Cardiology at Duke University Medical Center have used the Rankin General Clinical Research Center to study patients with atrial fibrillation and other common disorders of the heart rhythm. Atrial fibrillation is the most common disorder of the heart rhythm requiring treatment with antiarrhythmic drugs, and it accounts for over one-third of all U.S. hospitalizations for arrhythmias. Patients with atrial fibrillation have their usually normal heart rhythm replaced by periods of rapid, irregular heart beating that may cause a sense of pounding in the chest, shortness of breath, chest pain, dizziness, or loss of consciousness. These periods may last for minutes or hours, or they may last indefinitely unless acute treatment is given by a physician. Studies conducted on the Rankin General Clinical Research Center have concentrated on elucidating the mechanism, clinical course, and optimal treatment of atrial fibrillation and related disorders of the heart rhythm. These studies have focused on measuring the frequency of spontaneous occurrence of atrial fibrillation and paroxysmal supraventricular tachycardia. Among 150 patients studied who had their antiarrhythmic drug therapy withdrawn, one-half had a spontaneous, symptomatic recurrence in about 3 weeks; in fact, about 1 in 5 had a symptomatic recurrence of their arrhythmia in less than 1 day. The average heart rate during recurrences was 132 beats/min for patients with atrial fibrillation and 198 beats/min for patients with paroxysmal supraventricular tachycardia. Among the patients with atrial fibrillation, about 1 in 9 had a second arrhythmia, atrial flutter, recorded along with fibrillation. The frequency of asymptomatic arrhythmias was approximately 12 times the rate of symptomatic arrhythmias. Curiously, quality of life was not affected by the frequency of arrhythmia occurrence. Similar methods were used to study patients with ventricular tachycardia who had an implanted cardioverter defibrillator (ICD). The frequency of ICD shocks in this population provided an estimate of the occurrence of ventricular tachycardia. About 1/3 of the patients had an episode of ventricular tachycardia within 1 month. Results of these studies are important for designing clinical trials of chronic antiarrhythmic drug therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MECHANISM AND BEHAVIOR OF SYMPTOMATIC TACHYCARDIA
-
批准号:6565344
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2001
-
负责人:EDWARD L PRITCHETT
-
依托单位:
ATRIAL FIBRILLATION FOLLOW UP OF RHYTHM MANAGEMENT (AFFIRM)
-
批准号:6565362
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2001
-
负责人:EDWARD L PRITCHETT
-
依托单位:
OPEN LABEL TRIAL OF AZIMILIDE IN SUPRAVENTRICULAR ARRHYTHMIAS
-
批准号:6565324
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2001
-
负责人:EDWARD L PRITCHETT
-
依托单位:
MECHANISM AND BEHAVIOR OF SYMPTOMATIC TACHYCARDIA
-
批准号:6463047
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2000
-
负责人:EDWARD L PRITCHETT
-
依托单位:
OPEN LABEL TRIAL OF AZIMILIDE IN SUPRAVENTRICULAR ARRHYTHMIAS
-
批准号:6503064
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2000
-
负责人:EDWARD L PRITCHETT
-
依托单位:
ATRIAL FIBRILLATION FOLLOW UP OF RHYTHM MANAGEMENT (AFFIRM)
-
批准号:6415303
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2000
-
负责人:EDWARD L PRITCHETT
-
依托单位:
MECHANISM AND BEHAVIOR OF SYMPTOMATIC TACHYCARDIA
-
批准号:6503084
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2000
-
负责人:EDWARD L PRITCHETT
-
依托单位:
ATRIAL FIBRILLATION FOLLOW UP OF RHYTHM MANAGEMENT (AFFIRM)
-
批准号:6463065
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2000
-
负责人:EDWARD L PRITCHETT
-
依托单位:
ATRIAL FIBRILLATION FOLLOW UP OF RHYTHM MANAGEMENT (AFFIRM)
-
批准号:6503102
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2000
-
负责人:EDWARD L PRITCHETT
-
依托单位:
OPEN LABEL TRIAL OF AZIMILIDE IN SUPRAVENTRICULAR ARRHYTHMIAS
-
批准号:6415265
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2000
-
负责人:EDWARD L PRITCHETT
-
依托单位:
OPEN LABEL TRIAL OF AZIMILIDE IN SUPRAVENTRICULAR ARRHYTHMIAS
-
批准号:6463027
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2000
-
负责人:EDWARD L PRITCHETT
-
依托单位:
ATRIAL FIBRILLATION FOLLOW UP OF RHYTHM MANAGEMENT (AFFIRM)
-
批准号:6112786
-
项目类别:
-
资助金额:$4.09万
-
财政年份:1998
-
负责人:EDWARD L PRITCHETT
-
依托单位:
MECHANISM AND BEHAVIOR OF SYMPTOMATIC TACHYCARDIA
-
批准号:6112731
-
项目类别:
-
资助金额:$4.09万
-
财政年份:1998
-
负责人:EDWARD L PRITCHETT
-
依托单位:
OPEN LABEL TRIAL OF AZIMILIDE IN SUPRAVENTRICULAR ARRHYTHMIAS
-
批准号:6112757
-
项目类别:
-
资助金额:$4.09万
-
财政年份:1998
-
负责人:EDWARD L PRITCHETT
-
依托单位:
MECHANISM AND BEHAVIOR OF SYMPTOMATIC TACHYCARDIA
-
批准号:6273965
-
项目类别:
-
资助金额:$2.88万
-
财政年份:1997
-
负责人:EDWARD L PRITCHETT
-
依托单位:
PLACEBO CONTROLLED TRIAL OF AZIMILIDE IN SUPRAVENTRICULAR ARRHYTHMIAS
-
批准号:6273990
-
项目类别:
-
资助金额:$2.88万
-
财政年份:1997
-
负责人:EDWARD L PRITCHETT
-
依托单位:
ATRIAL FIBRILLATION FOLLOW UP OF RHYTHM MANAGEMENT (AFFIRM)
-
批准号:6274020
-
项目类别:
-
资助金额:$2.88万
-
财政年份:1997
-
负责人:EDWARD L PRITCHETT
-
依托单位:
OPEN LABEL TRIAL OF AZIMILIDE IN SUPRAVENTRICULAR ARRHYTHMIAS
-
批准号:6273991
-
项目类别:
-
资助金额:$2.88万
-
财政年份:1997
-
负责人:EDWARD L PRITCHETT
-
依托单位:
TECH. SUPPORT/NIEHS CLINICAL RESEARCH PROGRAM
-
批准号:6042908
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1993
-
负责人:EDWARD L PRITCHETT
-
依托单位:
TECH. SUPPORT/NIEHS CLINICAL RESEARCH PROGRAM
-
批准号:2854370
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1993
-
负责人:EDWARD L PRITCHETT
-
依托单位:
海外基金